HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of Aquacel Ag for Autogenous Skin Donor Sites.

Abstract
An ongoing objective of burn research is to evaluate wound dressings and develop new treatments to expedite wound healing. This was a single-center, prospective, randomized, controlled study to evaluate the effectiveness of Aquacel Ag as a dressing for autogenous skin donor sites compared with Xeroform. We hypothesized that donor sites treated with Aquacel Ag would heal faster. Patients were considered for enrollment if they required skin grafting with two donor sites >100 cm at least 2 inches apart. Dressings were observed daily starting on post-op day #2 until discharge and then weekly in the outpatient burn clinic. Assessments evaluated pain, infection, and reapplication. Photographs were taken on post-op day #2, upon "90% re-epithelialization," and at post-op day #30-45. Scar assessments and blinded photographic reviews were completed to assess cosmetic healing. Twenty-nine patients completed the study. Re-epithelialization occurred faster with Xeroform (15.2 days vs. 17.6 days). Daily pain scores were higher with Xeroform (6.72 vs. 5.68) and Aquacel Ag needed to be replaced more often (1.72 times vs. 0.10 times). Three patients developed donor site infections with Aquacel Ag. Scar scores between the donor sites were not statistically significant. The blinded photo review concluded that Xeroform had a better cosmetic outcome (24 vs. 10%). Although patients complained of more pain with Xeroform, it demonstrated shorter healing times and better cosmetic outcomes. Aquacel Ag needed to be replaced more often and represented the only three donor site infections.
AuthorsLinwood R Haith, Megan E Stair-Buchmann, Bruce H Ackerman, Diane Herder, Cynthia L Reigart, Marla Stoering, Robert E Guilday, Mary Lou Patton, Kerry M Ross
JournalJournal of burn care & research : official publication of the American Burn Association (J Burn Care Res) 2015 Nov-Dec Vol. 36 Issue 6 Pg. 602-6 ISSN: 1559-0488 [Electronic] England
PMID25501785 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Phenols
  • Carboxymethylcellulose Sodium
  • 2,4,6-tribromophenol
Topics
  • Adult
  • Burns (surgery)
  • Carboxymethylcellulose Sodium (pharmacology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Occlusive Dressings
  • Pain Measurement
  • Phenols (pharmacology)
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • Skin Transplantation
  • Transplant Donor Site
  • Transplantation, Autologous
  • Treatment Outcome
  • Wound Healing (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: